Functional Neuroimaging (fMRI) Biomarker of Allosteric Nicotinic Receptor Modulation in Mild Alzheimer's Disease Patients: A Razadyne vs. Aricept Dose Escalation Trial
Phase of Trial: Phase IV
Latest Information Update: 10 Apr 2013
At a glance
- Drugs Donepezil; Galantamine
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 06 Jun 2008 Status changed from recruiting to discontinued.
- 02 Feb 2007 Status changed from planning to recruiting.
- 29 Oct 2006 New trial record.